Copyright Reports & Markets. All rights reserved.

Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status and Forecast (2017-2028)
      • 1.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Supply by Company

    • 2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Company
    • 2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Company
    • 2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Company
    • 2.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status by Type

    • 3.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Type Introduction
      • 3.1.1 Invokana (Canagliflozin)
      • 3.1.2 Jardiance (Empagliflozin)
      • 3.1.3 Farxiga/Forxiga (Dapagliflozin)
      • 3.1.4 Suglat (Ipragliflozin)
    • 3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Type
      • 3.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Type (2017-2022)
      • 3.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Type (2017-2022)
      • 3.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status by Application

    • 4.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Application
      • 4.1.1 Hospital
      • 4.1.2 Medical Research Institute
      • 4.1.3 Other
    • 4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Application
      • 4.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Application (2017-2022)
      • 4.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Application (2017-2022)
      • 4.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status by Region

    • 5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Region
      • 5.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Region
      • 5.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Region
    • 5.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status
    • 5.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status
    • 5.4 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status
    • 5.5 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status
    • 5.6 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status

    6 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status

    • 6.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Country
      • 6.1.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Country (2017-2022)
      • 6.1.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status

    • 7.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Country
      • 7.1.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status

    • 8.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Country
      • 8.1.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status

    • 9.1 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Country
      • 9.1.1 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Status

    • 10.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Country
      • 10.1.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Cost Analysis
    • 11.5 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Channel and Distributors Analysis
      • 11.5.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Channel
      • 11.5.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors
    • 11.6 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Downstream Major Buyers

    12 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast by Type and by Application

    • 12.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Type
      • 12.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Forecast by Type
      • 12.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Forecast by Type
      • 12.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Type
    • 12.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Application
      • 12.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Forecast by Application
      • 12.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Forecast by Application
      • 12.3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Application

    13 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast by Region/Country

    • 13.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast by Region (2023-2028)
      • 13.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Kotobuki Pharmaceutical
      • 14.1.1 Company Information
      • 14.1.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
      • 14.1.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Janssen Pharmaceuticals
      • 14.2.1 Company Information
      • 14.2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
      • 14.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Eli Lilly
      • 14.3.1 Company Information
      • 14.3.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
      • 14.3.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Bristol Myers Squibb
      • 14.4.1 Company Information
      • 14.4.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
      • 14.4.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Boehringer Ingelheim
      • 14.5.1 Company Information
      • 14.5.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
      • 14.5.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 AstraZeneca
      • 14.6.1 Company Information
      • 14.6.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
      • 14.6.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Astellas
      • 14.7.1 Company Information
      • 14.7.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
      • 14.7.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis

    ...

      15 Conclusion

        16 Methodology

        This report provides a comprehensive analysis of current global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

        According to GRD Survey, the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

        Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

        The Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market has been exhibited in detail in the following chapters
        Chapter 1 displays the basic product introduction and market overview.
        Chapter 2 provides the competition landscape of global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industry.
        Chapter 3 provides the market analysis by type and by region
        Chapter 4 provides the market analysis by application and by region
        Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
        Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
        Chapter 12 provides the market forecast by type and by application
        Chapter 13 provides the market forecast by region
        Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
        Chapter 15 conclusions

        Segmented by Type
        Invokana (Canagliflozin)
        Jardiance (Empagliflozin)

        Segmented by Application
        Hospital
        Medical Research Institute
        Other

        Segmented by Country
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
        Central & South America
        Brazil
        Argentina
        Colombia
        Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

        Key manufacturers included in this survey
        Eli Lilly
        Bristol Myers Squibb
        Boehringer Ingelheim
        AstraZeneca
        Astellas
        Buy now